Von Hippel-Lindau Disease Market Is Driven by Targeted Therapies

adicionou um novo artigo Health

2025-05-05 12:39:11 -

The Von Hippel-Lindau Disease (VHLD) market encompasses diagnostic tools, targeted therapies, and supportive care solutions developed to manage this rare genetic disorder characterized by hemangioblastomas, renal cell carcinoma, and pheochromocytomas. Key products include advanced molecular diagnostics for VHL gene mutations, small-molecule inhibitors such as tyrosine kinase inhibitors (TKIs),...

0 Comentários 0 Compartilhamentos 199 Visualizações 0 Anterior